Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11.07. | Case builds for Biogen, Stoke's Dravet syndrome drug | ||
11.07. | AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody | ||
11.07. | Bayer bags first world approval for hot flush therapy | ||
11.07. | Cash injection will help Varda make drugs in space | ||
10.07. | Just how radical is the FDA's complete response letter move? | ||
10.07. | EU President fends off no-confidence vote over Pfizer texts | ||
10.07. | 'Diabetes Barbie' launches with medtech accessories | ||
10.07. | UK authority cracks down on weight-loss drug ads | ||
10.07. | US measles elimination status at risk as cases soar | ||
10.07. | NICE backs new drugs for Crohn's disease, lymphoma | ||
09.07. | FDA clears new, safer regimen for Lilly's Alzheimer's drug | ||
09.07. | Concentra throws lifeline to troubled CARGO Therapeutics | ||
09.07. | Update: MSD confirms $10bn takeover deal for Verona Pharma | ||
09.07. | Novo Nordisk files high-dose Wegovy in EU | ||
09.07. | Is MSD preparing a $10bn deal to buy Verona Pharma? | ||
09.07. | New radiopharma Actithera emerges with $75.5m in financing | ||
08.07. | Taiho's late-stage Duchenne candidate fails trial | ||
08.07. | Boehringer raises hope of oral drug for diabetic eye disease | ||
08.07. | First malaria drug for newborns and young infants cleared | ||
08.07. | Medical groups sue RFK Jr over COVID-19 policies | ||
08.07. | Samsung builds digital health credentials with Xealth buy | ||
07.07. | Apogee rises as long-acting eczema drug heads for phase 3 | ||
07.07. | KalVista bags FDA approval for delayed oral HAE drug | ||
07.07. | Charities call for shake-up in UK rare disease R&D | ||
07.07. | Trump signs Medicaid-slashing budget into law |